Andrew R. Jordan

Insider Reports History

Entity
Individual
Location
C/O Guilford Pharmaceuticals Inc, 6611 Tibutary St., Baltimore, MD
Signature
/s/ John J. Kirby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew R. Jordan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aceragen, Inc. CHIEF STRATEGY OFFICER Common Stock 452K $230K $0.51 Jan 17, 2023 Direct
Aceragen, Inc. CHIEF STRATEGY OFFICER Stock Options (Right to Buy) 25.4K Jan 20, 2023 Direct
Aceragen, Inc. CHIEF STRATEGY OFFICER Series Z Convertible Preferred Stock 0 Jan 17, 2023 Direct

Insider Reports Filed by Andrew R. Jordan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACGN Aceragen, Inc. Jan 20, 2023 1 $0 4 Feb 2, 2023 CHIEF STRATEGY OFFICER
ACGN Aceragen, Inc. Jan 17, 2023 2 $0 4 Jan 19, 2023 Chief Strategy Officer
IDRA IDERA PHARMACEUTICALS, INC. Jan 6, 2023 2 -$52.5K 4 Jan 10, 2023 CHIEF STRATEGY OFFICER
IDRA IDERA PHARMACEUTICALS, INC. Sep 28, 2022 2 $0 4 Sep 30, 2022 Chief Strategy Officer
IDRA IDERA PHARMACEUTICALS, INC. Sep 28, 2022 0 $0 3 Sep 30, 2022 Chief Strategy Officer